NCT01041911View on ClinicalTrials.gov

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
Hemorrhoids
Interventions
DRUG

Euphorbia tablets

50 mg, tablet, once daily, 14 days

DRUG

Euphorbia tablets

100 mg, tablet, once daily, 14 days

DRUG

Euphorbia tablets

200 mg, tablet, 2 tablets of 100 mg Euphorbia prostrata, 14 days

DRUG

Placebo tablets

placebo, tablet, once daily, 14 days

Trial Locations (6)

110002

Maulana Azad Medical College, New Delhi

110064

Deen Dayal Upadhyay Hospital, Hari Nagar, New Delhi, New Delhi

400008

Grant Medical College, Mumbai

400601

Nath Hospital, Golden Heaven Society, Opp Janta Sahakari Bank,, Thāne

Sahil Hospital, Tawdw Niwas, 1st Floor Khopat, Thane (W), Thāne

560002

Bangalore Medical College, Bangalore

Sponsors

Lead Sponsor

Panacea Biotec Ltd
All Listed Sponsors
lead

Panacea Biotec Ltd

INDUSTRY

NCT01041911 - To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids | Biotech Hunter | Biotech Hunter